James Lynam

3.0k total citations
26 papers, 133 citations indexed

About

James Lynam is a scholar working on Public Health, Environmental and Occupational Health, Surgery and Molecular Biology. According to data from OpenAlex, James Lynam has authored 26 papers receiving a total of 133 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 7 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in James Lynam's work include Glioma Diagnosis and Treatment (6 papers), Palliative Care and End-of-Life Issues (5 papers) and Cancer Genomics and Diagnostics (4 papers). James Lynam is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Palliative Care and End-of-Life Issues (5 papers) and Cancer Genomics and Diagnostics (4 papers). James Lynam collaborates with scholars based in Australia, United States and Canada. James Lynam's co-authors include Christine Paul, James P. Newcombe, Jill Thistlethwaite, Emma Bartle, Chris Roberts, Marjorie M. Walker, Mark W Davies, Priya Khanna, Hubert Hondermarck and Chen Chen Jiang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

James Lynam

23 papers receiving 132 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Lynam Australia	6	51	29	26	21	18	26	133
Angad Beniwal United States	7	62 1.2×	83 2.9×	27 1.0×	34 1.6×	8 0.4×	14	237
Samantha E. Hoffman United States	7	23 0.5×	22 0.8×	27 1.0×	20 1.0×	2 0.1×	26	152
Tariq Al‐Saadi Canada	7	28 0.5×	19 0.7×	48 1.8×	13 0.6×	6 0.3×	45	164
Mindy X. Wang United States	9	21 0.4×	12 0.4×	17 0.7×	16 0.8×	3 0.2×	24	180
Albert Antar United States	8	13 0.3×	11 0.4×	16 0.6×	22 1.0×	11 0.6×	18	143
Aaron Richman United States	6	16 0.3×	16 0.6×	7 0.3×	27 1.3×	13 0.7×	22	139
Marylee M. Kott United States	9	23 0.5×	14 0.5×	46 1.8×	33 1.6×	9 0.5×	17	191
Eric R. Manahan United States	6	34 0.7×	11 0.4×	77 3.0×	51 2.4×	117 6.5×	6	343
Ashlyn S. Everett United States	5	15 0.3×	6 0.2×	41 1.6×	7 0.3×	12 0.7×	16	99
Mackenzie W. Sullivan United States	9	32 0.6×	2 0.1×	53 2.0×	19 0.9×	18 1.0×	33	222

Countries citing papers authored by James Lynam

Since Specialization

Citations

This map shows the geographic impact of James Lynam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Lynam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Lynam more than expected).

Fields of papers citing papers by James Lynam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Lynam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Lynam. The network helps show where James Lynam may publish in the future.

Co-authorship network of co-authors of James Lynam

This figure shows the co-authorship network connecting the top 25 collaborators of James Lynam. A scholar is included among the top collaborators of James Lynam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Lynam. James Lynam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tie, Jeanne, Yuxuan Wang, Jonathan M. Loree, et al.. (2025). LBA9 ctDNA-guided adjuvant chemotherapy de-escalation in stage III colon cancer: Primary analysis of the ctDNA-negative cohort from the randomized AGITG DYNAMIC-III trial (Intergroup study of AGITG and CCTG). Annals of Oncology. 36. S1572–S1572.

Paul, Christine, Nicole M. Verrills, Stephen P. Ackland, et al.. (2024). The impact of a regionally based translational cancer research collaborative in Australia using the FAIT methodology. BMC Health Services Research. 24(1). 320–320.

Walker, Marjorie M., et al.. (2024). ‘I think both of us drew strength from it’: qualitative reflections from next of kin following the death and post-mortem brain donation of a loved one with brain cancer. Palliative Care and Social Practice. 18. 396569898–396569898. 1 indexed citations

Walker, Marjorie M., et al.. (2024). “I’m standing next to him, I’m supporting him”—Supporting a loved one with brain cancer to donate their brain: A qualitative study. Neuro-Oncology Practice. 11(6). 813–820.

Hong, Martin, et al.. (2024). The impact of brain cancer care coordinators on healthcare utilization and outcomes in patients with glioblastoma. Neuro-Oncology Practice. 11(5). 575–582. 2 indexed citations

Faulkner, Sam, Phillip Jobling, Robert A. Rush, et al.. (2023). ProNGF Expression and Targeting in Glioblastoma Multiforme. International Journal of Molecular Sciences. 24(2). 1616–1616. 5 indexed citations

Walker, Marjorie M., et al.. (2023). Understanding the value of brain donation for research to donors, next-of-kin and clinicians: A systematic review. PLoS ONE. 18(12). e0295438–e0295438. 4 indexed citations

Lewin, Jeremy, Andrew Weickhardt, James Lynam, et al.. (2023). Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations. JCO Oncology Practice. 19(11). 973–980. 3 indexed citations

Faulkner, Sam, et al.. (2023). The Membrane Protein Sortilin Is a Potential Biomarker and Target for Glioblastoma. Cancers. 15(9). 2514–2514. 5 indexed citations

10.

Faulkner, Sam, et al.. (2023). Targeting XBP1 mRNA splicing sensitizes glioblastoma to chemotherapy. FASEB BioAdvances. 5(5). 211–220. 6 indexed citations

11.

Sridharan, Swetha, Fiona Day, James Lynam, et al.. (2022). Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer. Radiation Oncology. 17(1). 158–158. 2 indexed citations

12.

Parakh, Sagun, Daniel Roos, Amal Abou‐Hamden, et al.. (2022). Adult medulloblastoma in an Australian population. Journal of Clinical Neuroscience. 102. 65–70. 1 indexed citations

13.

Day, Fiona, Swetha Sridharan, James Lynam, et al.. (2022). Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group). BMC Cancer. 22(1). 1324–1324. 2 indexed citations

14.

Tie, Jeanne, Joshua D. Cohen, Kamel Lahouel, et al.. (2022). Adjuvant chemotherapy guided by circulating tumor DNA analysis in stage II colon cancer: The randomized DYNAMIC trial.. Journal of Clinical Oncology. 40(17_suppl). LBA100–LBA100. 3 indexed citations

15.

McCarter, Kristen, et al.. (2021). A qualitative study investigating Australian cancer service outpatients’ experience of distress screening and management: what is the personal relevance, acceptability and improvement opportunities from patient perspectives?. Supportive Care in Cancer. 30(3). 2693–2703. 5 indexed citations

16.

Navani, Vishal, James Lynam, Steven G. Smith, Christine J. O’Neill, & Christopher W. Rowe. (2021). Castration failure in prostate carcinoma due to a functioning adrenocortical carcinoma. Endocrinology Diabetes and Metabolism Case Reports. 2021. 1 indexed citations

17.

Vilain, Ricardo E., Simon J. King, James Lynam, et al.. (2021). Mind Over Matter: Confronting Challenges in Post-Mortem Brain Biobanking for Glioblastoma Multiforme. Biomarker Insights. 16. 3399279855–3399279855. 4 indexed citations

18.

Paul, Christine, et al.. (2021). Postmortem brain donations vs premortem surgical resections for glioblastoma research: viewing the matter as a whole. Neuro-Oncology Advances. 4(1). vdab168–vdab168. 10 indexed citations

19.

Ngo, D., Leonard Kritharides, Janette L. Vardy, et al.. (2020). Factors Associated with Adverse Cardiovascular Events in Cancer Patients Treated with Bevacizumab. Journal of Clinical Medicine. 9(8). 2664–2664. 20 indexed citations

20.

Arulananda, Surein, et al.. (2018). Clinical correlates of severe thrombocytopenia from temozolomide in glioblastoma patients. Internal Medicine Journal. 48(10). 1206–1214. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact